Why the study?
What is the efficacy of various antiplatelet agents for the primary and secondary prevention of stroke?
Population
Patients requiring secondary prevention of stroke, patients with atrial fibrillation and contraindications…
Comparison
Antiplatelet agents including aspirin… vs Warfarin, or other antiplatelet regimens
Design
Review
Authors
Loading...
Supports aspirin in secondary prevention and AF alternatives; leaves open primary prevention utility in low-risk elderly.
What is the efficacy of various antiplatelet agents for the primary and secondary prevention of stroke?
Aspirin remains an effective agent for secondary stroke prevention and an alternative for atrial fibrillation patients contraindicated for warfarin, though its role in primary prevention for low-risk elderly is not supported.
Mark L. Dyken (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: